Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$21,422,841
-$3,358,058 QoQ
Shares Held
227,612
-9.3% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. INCY ranks #20 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,422,841 | 227,612 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $24,780,899 | 250,895 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,302,633 | 121,479 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,395,396 | 152,649 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,540,389 | 207,108 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,112,604 | 378,060 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,533,832 | 310,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,506,872 | 371,278 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,340,556 | 216,615 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,204,555 | 194,371 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,625,520 | 183,928 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,180,302 | 163,539 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,669,436 | 119,959 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,938,411 | 111,285 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,594,028 | 83,944 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,852,038 | 90,194 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,661,567 | 96,469 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,893,437 | 121,164 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,441,117 | 79,109 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,861,757 | 69,675 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,620,172 | 44,545 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,689,586 | 19,425 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,493,425 | 27,785 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,313,523 | 31,870 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,347,021 | 32,050 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||